Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

CUSIP: 747324101

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
62,130,557
Total 13F shares
18,338,628
Share change
+18,328,628
Total reported value
$199,903,000
Price per share
$10.97
Number of holders
51
Value change
+$199,792,959
Number of buys
50

Quarterly Holders Quick Answers

What is CUSIP 747324101?
CUSIP 747324101 identifies PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Bayer World Investments B.V.
3/4/5
Former 10% Owner —
class O/S missing
2,742,338
 $3,839,273 — 13 Oct 2021
3/4/5
Cormorant Asset Management, LP
3/4/5
Former 10% Owner —
class O/S missing
1,118,854
 $1,566,396 — 13 Oct 2021
3/4/5
Ronald Herbst
3/4/5
Chief Scientific Officer —
mixed-class rows
118,674
mixed-class rows
 $234,796 — 07 Oct 2021
3/4/5
Ritu Shah
3/4/5
Chief Operating Officer —
class O/S missing
31,344
 $120,048 — 07 Oct 2021
3/4/5

Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) as of Q4 2021

As of 31 Dec 2021, Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,338,628 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, PERCEPTIVE ADVISORS LLC, BVF INC/IL, CITADEL ADVISORS LLC, JANUS HENDERSON GROUP PLC, Laurion Capital Management LP, HHLR ADVISORS, LTD., ACUTA CAPITAL PARTNERS, LLC, and Cormorant Asset Management, LP. This page lists 51 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q4 2025 Across Filers

Q4 2025 holders
78
Q4 2021 holders
51
Holder diff
-27
Investor Q4 2025 Shares Q4 2021 Shares Share Diff Share Chg % Q4 2025 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .